Alternative therapies for asthma

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 1, 1997, Pages 61-71

  Ziment, Irwin ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIURETIC AGENT; MAGNESIUM;

ALTERNATIVE MEDICINE; ASTHMA; CHINESE MEDICINE; DIET SUPPLEMENTATION; DIET THERAPY; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL PLANT; METHODOLOGY; NEBULIZER; PSYCHOLOGICAL ASPECT; REVIEW; SODIUM RESTRICTION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; COMPLEMENTARY THERAPIES; DIET, SODIUM-RESTRICTED; DIURETICS; DRUG DELIVERY SYSTEMS; FOOD, FORTIFIED; HUMANS; MAGNESIUM; MEDICINE, CHINESE TRADITIONAL; NEBULIZERS AND VAPORIZERS; PLANTS, MEDICINAL;

EID: 0030637818     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199701000-00010     Document Type: Article

References (93)

1. Jorgensen RK, Butterfield JH, Kao PL, Frigas E: Alternative medicines for asthma. Allergy 1996, 51(Suppl 30):57.
2. Brown E: Alternative medicine converts its skeptics. Managed Healthcare 1996, 1:24-28.
3. Neiko V, Neiko E, Vinnik B: Laser therapy effectiveness while treating asthmatic syndrome patients suffering from rheumatoid arthritis. Allergy 1996, 51(Suppl 30):55.
4. MacLennan AH, Wilson DH, Taylor AW: Prevalence and cost of alternative medicine in Australia. Lancet 1996, 347:569-573.
5. Kristoffersen SS, Atkin PA, Shenfield GM: Uptake of alternative medicine. Lancet 1996, 347:972.
6. Cooper C: Book review: Micozzi MS (ed): Fundamentals of complementary and alternative medicine. New York: Churchill Livingstone, 1996. Lancet 1996, 347:956.
7. Ernst E, Resch K-L, White AR: Complementary medicine. What physicians think of it: a meta-analysis. Arch Intern Med 1995, 155:2405-2408. These investigators from the Center for Complementary Health Sciences in Exeter, England, evaluated 12 surveys of physicians' attitudes to complementary medicine. Such alternatives may be useful for patients, but more studies are needed to evaluate effectiveness. Physicians may use alternatives as helpful placebos, and it is currently concluded that there may be an increasing lack of conviction about the specific value attributed to individual alternative practices.
8. Lewith GT: Asthma: a complementary medical perspective. Complementary Therapes in Medicine 1996, 4:106-111.
9. Japanese Society for Allergology: Guidelines for the diagnosis and management of bronchial asthma. Allergy 1995, 50(Suppl 30):16-22.
10. Editorial: Kampo medicine, a source of drugs waiting to be exploited. Lancet 1996, 348:5-6.
11. Yaoi H: Broad neurovegetative effects of "Yaoi impact therapy" (YIT) on asthma. Allergy 1996, 51(Suppl 30):57.
12. Turner DM: Natural product source material used in the pharmaceutical industry: the Glaxo experience. J Ethnopharmacol 1996, 51:39-44.
13. Pachter LM, Cloutier MM, Bernstein BA: Ethnomedical (folk) remedies for childhood asthma in a mainland Puerto Rican community. Arch Pediatr Adolesc Med 1995, 149:982-989.
14. Duran-Tauleria E, Rona RJ, Chinn S, Burney P: Influence of ethnic group on asthma treatment in children in 1990-1: national cross-sectional study. BMJ 1996, 313:148-152.
15. Barnes P: Future trends in asthma therapy. Respir Med 1996, 90:14-16.
16. News: Complementary medicine is booming world wide. BMJ 1996, 313:131-133.
17. Gamble A: Alternative medical approaches to the treatment of asthma. Alternative and Complementary Therapies 1995, Jan/Feb:61-66.
18. Ernst E, Resch KL: Concept of true and perceived placebo effects. BMJ 1995, 311:551-553.
19. Nielsen NH, Bronfort G, Bendix T, Madsen F, Weeke B: Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial. Clin Exp Allergy 1995, 25:80-88.
20. Jobst KA: A critical analysis of acupuncture in pulmonary disease: efficacy and safety of the acupuncture needle. Journal of Alternative and Complementary Medicine Alternat Complement Med 1995, 1:57-85. This is a very comprehensive review, and the author concludes that acupuncture is useful in bronchospastic diseases. Although the author is prejudiced in favor of alternative medicine (he is the European Editor of the new J Alternat Complement Med), the review should be given careful attention. Further controlled studies may help delineate the true value of this popular modality.
21. Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL: Panic, anxiety, dyspnea and respiratory disease. Am J Respir Crit Care Med 1996, 154:6-17.
22. Bosley CM, Fostbury JA, Cochrane GM: The psychological factors associated with poor compliance in asthma. Eur Respir J 1995, 8:899-904.
23. Joseph KS, Blais L, Ernst P, Suissa S: Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquilisers. BMJ 1996, 312:79-83.
24. Emtner M, Herala M, Stålenheirn G: High-intensity physical training in adults with asthma. A 10-week rehabilitation program. Chest 1996, 109:323-330.
25. Shim C: Depot triamcinolone for patients with severe asthma and medication non-compliance. Am J Respir Crit Care Med 1996, 153(Pt 2):A342.
26. Mobeireek A, Alhamad A, Al-Subaei A, Alzeer A: Psychogenic vocal cord dysfunction simulating bronchial asthma. Eur Respir J 1995, 8:1978-1981.
27. McFadden ER Jr, Zawadski DK: Vocal cord dysfunction masquerading as exercise-induced asthma. A physiologic cause for "choking" during athletic activities. Am J Respir Crit Care Med 1996, 153:942-947. Refractory exercise-induced asthma in athletes may need to be evaluated with sophisticated studies, including isocapnic hyperventilation of frigid air, maximum exercise challenge, methacholine challenge, spirometry and maximal expiratory flow-volume curves, and direct laryngoscopy. Such careful studies are essential for the diagnosis of psychogenic vocal cord dysfunction.
28. Britton J: Dietary fish oil and airway obstruction. Thorax 1995, 50(Suppl 1):S11-S15. This article reviews the value of n-3 polyunsaturated fatty acids in bronchospastic diseases. Although patients with asthma are not significantly benefited by this therapy, smokers who ingest fish oil may have a slower rate of progression of chronic obstructive pulmonary disease.
29. Gorelova JY: W-3 and W6 Pufa in treatment of paediatric bronchial asthma. Allergy 1996, 51:90.
30. Ye VZC, Duggan KA: The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung. Chest 1995, 108:535-538.
31. Demissie K, Ernst P, Donald KG, Joseph L: Usual dietary salt intake and asthma in children: a case-control study. Thorax 1996, 51:59-63.
32. Devereux G, Beach JR, Bromly C, Avery AJ, Ayatollahi SMT, Williams SM, Stenton SC, Bourke SJ, Hendrick DJ: Effects of dietary sodium on airways responsiveness and its importance in the epidemiology of asthma: an evaluation in three areas of northern England. Thorax 1995, 50:941-947.
33. Tunnicliffe WS, Baker JC, Duncanson RC, Ayres JG: Reduced dietary intakes of magnesium, selenium and vitamins A, C, and E in patients with brittle asthma [abstract]. Am J Respir Crit Care Med 1996, 153(Pt 2):A515.
34. Peat JK, Xuan W, Salome CM, Hodge L, Woolcock AJ: Dietary risk factors for asthma in susceptible children [abstract]. Am J Respir Crit Care Med 1996, 153(Pt 2):A255.
35. Bernstein WK, Khastgir T, Khastgir A, Hernandez E, Miller J, Schonfeld SA, Nissin JE, Chernow B: Lack of effectiveness of magnesium in chronic stable asthma. Arch Intern Med 1995, 155:271-176.
36. Bloch H, Silverman R, Mancherje N, Grant S, Jagminas L, Scharf SM: Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995, 107:1576-1581.
37. Hill JM, Lewis S, Britton J: Effect of inhaled magnesium sulphate on airflow in asthmatic subjects. Am J Respir Crit Care Med 1996, 153(Pt 2):A350.
38. Leung R, Thien FCK, Baldo B, Czarny D: Royal jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. J Allergy Clin Immunol 1995, 96:1004-1007.
39. Businco L, Falconieri P, Giampietro P, Bellioni B: Food allergy and asthma. Pediatric Pulmonology 1995, 11(Suppl):59-60.
40. Shorokhova TD, Yusupova RS, Dovodneva EP, Migdalovich MG, Gokhberg EA, Kryuchkova JA: The immunomodulating and antioxidant effect of the food supplement "Bioton" in patients with infection-induced bronchial asthma. Allergy 1996, 51(Suppl 30):54.
41. Shimoda T, Kohno S, Takao A, Fujiwara C, Matsuse H, Sakai H, Watanabe T, Hara K, Asai S: Investigation of the mechanism of alcohol-induced bronchial asthma. J Allergy Clin Immunol 1996, 97:74-84.
42. Myou S, Fujimura M, Nishi K, Ohka T, Matsuda T: Inhibitory effect of terfenadine, a selective H, histamine antagonist, on alcoholic beverage-induced bronchocontriction in asthmatic patients. Eur Respir J 1995, 8:619-623.
43. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ: The effect of alcoholic ingestion on exhaled nitric oxide. Eur Respir J 1996, 9:1130-1133.
44. Barnes PJ: NO or no NO in asthma? Thorax 1996, 51:218-220. This brief review points out that nitric oxide is derived from L-arginine by nitric oxide-synthase in epithelial cells. Increased levels of nitric oxide occur in asthma and may cause bronchodilation by inhibiting cholinergic bronchoconstriction. However, nitric oxide may amplify the asthmatic inflammatory response to a greater degree.
45. Tattersfield AE: Air pollution: brown skies research. Thorax 1996, 51:13-22. This lecture emphasizes that pollution is not a major initiator of asthma, although it may have a small effect in causing exacerbations. This view is not shared by Lebowitz [47].
46. Carnall D: Effect of air pollution on asthma is "small." BMJ 1995, 311:1120.
47. Lebowitz MD: Epidemiological studies of the respiratory effects of air pollution. Eur Respir J 1996, 9:1029-1054. This detailed review examines the extensive literature and emphasizes the variability of the response of asthmatic patients to different types of pollution. However, pollution is presented as a major cause of exacerbations.
48. Lemko O, Lemko I: The non-medicamental prevention of bronchial asthma. Tuber Lung Dis 1994, 75(Suppl):122.
49. Geniçoglu A, Artvinli M: Speleotherapy. An alternative therapy in COPD patients. Allergy 1996, 51(Suppl 30):54.
50. Lemko I, Korshinska M, Lemko O, Kopinets I: Aerosalt therapy of bronchial asthma: different approaches depending on the disease clinical manifestations. Allergy 1996, 51(Suppl 30):54.
51. Sharkey P, Portnoy J: Rush immunotherapy: experience with a one-day schedule. Ann Allergy 1996, 76:175-180.
52. Barnes PJ: Is immunotherapy for asthma worthwhile? N Engl J Med 1996, 334:531-532.
53. Field SK, Underwood M, Brant R, Cowie RL: Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996, 109:316-322.
54. Dal Negro R, Pomari C, Micheletto C, Turco P: Omeprazole (OM), but not placebo (P), reduces the bronchial response to methacholine (MCH) in mild non-atopic asthmatics with gastroesophageal reflux (GER). Am J Respir Crit Care Med 1996, 153(Pt 2):A517.
55. Ayres JG, Miles JF: Oesophageal reflux and asthma. Eur Respir J 1996, 9:1073-1078.
56. Marquette C-H, Stach B, Cardot E, Bervar JF, Saulnier F, Lafitte JJ, Goldstein P, Wallaert B, Tonnel A-B: High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J 1995, 8:22-27.
57. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ: Chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995, 75:1172-1178. This study extends the earlier work on oral steroids done by the National Jewish Center for Immunology and Respiratory Medicine. The finding that aerosol steroid, given once-a-day at 3 p.m., was effective and caused no side effects may influence others to extend this interesting observation.
58. Moss RB: Alternative pharmacotherapies for steroid-dependent asthma. Chest 1995, 107:817-825.
59. Hill JM, Tattersfield AE: Corticosteroid sparing agents in asthma. Thorax 1995, 50:577-582.
60. Kanzoro G, Nowak D, Magnussen H: Short term effect of methotrexate in severe steroid-dependent asthma. Lung 1995, 173:223-231.
61. Nizankowska E, Soja J, Pinis G, Bochenek G, Sladek K, Domagala B, Pajak A, Szezeklik A: Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J 1995, 8:1091-1099.
62. Lock SA, Kay AB, Barnes NC: Double-blind, placebo controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med 1996, 153:509-514.
63. Busse WW, Middleton E, Storms W, Dockhorn RJ, Chu TJ, Grossman J, Weiler JM, Bronsky EA, Mansfield LE, Bell TD, et al.: Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996, 153:122-127. Azelastine is a new anti-inflammatory drug with antihistaminergic properties. This study of 193 patients showed that azelastine was able to reduce dosing of inhaled beclomethasone by 25% to 30%. Because the drug also may reduce the need for β-agonists and theophylline, it may prove useful in more severe cases of asthma.
64. Ceyhan B, Celikel T: Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity. Chest 1995, 107:1009-1012.
65. Garrigo J, Danta I, Ahmed T: Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 1996, 153:1702-1707.
66. Diamant Z, Timmers MC, van der Veen H, Page CP, van der Meer FJ, Sterk PJ: Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am J Respir Crit Care Med 1996, 153:1790-1795.
67. Lisenko GI: Hemosorption in complex treatment of bronchial asthma. Allergy 1996, 51(Suppl 30):54.
68. Kogosova L, Kovalenko N, Tsygankova L, Novosad F, Nikolaenko N, Matvienko Y: Erbisol in immunorehabilitation of bronchial asthma (BA) patients. Allergy 1996, 51(Suppl 31):89.
69. Kokaia L, Bakhutashvili L, Telia A, Kherkheulidze P: Long-range use of Plaferon-LB against allergic bronchoconstriction. Allergy 1996, 51(Suppl 31):89.
70. Piotrowska T, Stasiak-Barmuta A, Hofman J: The clinical effects of immunomodulators in recurrent infections in children with bronchial asthma. Allergy 1996, 51(Suppl 31):90.
71. Hunt LW, Swedlund HA, Gleich GJ: Effect of nebulized lidocaine on severe glucocorticord-dependent asthma. Mayo Clin Proc 1996, 71:361-368.
72. Groeben H, Foster M, Brown RH: I.V. Iidocaine and oral mexiletine block reflex bronchoconstriction in asthmatics. Am J Respir Crit Care Med 1996, 153(Pt 2):A877.
73. Polosa R, Rajakularingam K, Prosperini G, Magri S, Mastruzzo C, Holgate ST: Inhaled loop diuretics and basal airway responsiveness in man: evidence of a role for cyclo-oxygenase products. Eur Respir J 1995, 8:593-599.
74. Pye S, Pavord I, Wilding P, Bennett J, Knox A, Tattersfield A: A comparison of the effects of inhaled furosemide and ethacrynic acid on sodium-metabisulfite-induced bronchoconstriction in subjects with asthma. Am J Respir Crit Care Med 1995, 151:337-339.
75. Pavord I, Holland E, Baldwin D, Tattersfield A, Knox A: Effect of diuretics on allergen-induced contractions of passively sensitized human bronchi in vitro. Am J Respir Crit Care Med 1995, 152:1164-1169.
76. Yates DH, O'Connor BJ, Yilmaz G, Aikman S, Wordsell M, Barnes PJ, Chung KF: Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. Am J Respir Crit Care Med 1995, 152:2173-2175.
77. Shimizu T, Mochizuki H, Maeda S, Shigeta M, Morikawa A, Kuroume T: Inhaled indomethacin prevents bronchoconstrictive response to distilled water but not to histamine in children with asthma. Am J Respir Crit Care Med 1995, 152:625-628.
78. 2 receptors. Am J Respir Crit Care Med 1996, 153(Pt2):A515.
79. Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B: Menopause, post-menstrual estrogen preparations, and the risk of adult onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995, 152:1183-1188.
80. Tamaoki J, Chiyotani A, Sakai A, Takemura H, Konno K: Effect of menthol vapour on airway responsiveness in patients with mild asthma. Respir Med 1995, 89:503-504.
81. Fee WH Jr: We need more studies on colchicine and airway reactivity. Chest 1995, 108:589-.
82. Pahn-Puibaraud TTC, Regnard J, Monchi M, Dal'Ava-Santucci J, Lockhart A, Dinh-Xuan AT: Effects of pretreatment with inhaled methoxamine on bronchial responses to histamine in asthmatic subjects. Eur Respir J 1995, 8:40-46.
83. Grandordy BM, Paiva de Carvalho J, Regnard J, Florentin D, de Lauture D, Marsac J, Lockhart A: The effect of intravenous phenylephrine on airway calibre in asthma. Eur Respir J 1995, 8:624-631.
84. Mascali JJ, Cvietusa P, Negri J, Borish L: Anti-inflammatory effects of theophylline: modulaiton of cytokine production. Ann Allergy Asthma Immunol 1996, 77:34-38.
85. Banner KH, Page CP: Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995, 8:996-1000.
86. Montserrat JM, Barbera JA, Viegas C, Roca J, Rodriguez-Roisin R: Gas exchange response to intravenous aminophylline in patients with a severe exacerbation of asthma. Eur Respir J 1995, 8:28-33.
87. Smaldone GC: Aerosolized drug delivery in the 90s. Chest 1996, 110:316-317.
88. Ahrens R, Lux C, Bahl T, Han S-H: Choosing the metered dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995, 96:288-294. This study reveals that the amount of a particular drug delivered to the lung from a metered dose inhaler can be markedly influenced by the particular qualities of a reservoir in conjunction with the respective inhaler. These considerable variations should be recognized by clinicians, and the topic merits further research by the pharmaceutical industry.
89. Wildhaber J, Devadason SG, Hayden MJ, Sumers QA, LeSouëe PN: Effect of electrostatic charge on salbutamol delivery from plastic spacers. Am J Respir Crit Care Med 1996, 153(Pt 2):A60.
90. Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM: Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996, 110:498-505.
91. Pedersen S: Inhalers and nebulizers: which to choose and why. Respir Med 1996, 90:69-77.
92. Moler FW, Johnson CE, Van Laanen C, Palmisano JM, Nasr SZ, Akingbola O: Continuous versus intermittent nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med 1995, 151:602-606.
93. O'Donohue WJ Jr: Guidelines for the use of nebulizers in the home and at domiciliary sites. Reports of a consensus conference. Chest 1996, 109:814-820.